Studies in economics at the University of Bielefeld
PhD on National Innovation Systems in Transition Countries at Bielefeld University, research stay at the Centre for Innovation, Research and Competence in the Learning Economy (CIRCLE) at Lund University, Sweden
Since 2009 at the IW in the cluster State, taxes and social security
until January 2021 Senior Economist at the Research Unit Pharmaceutical Location Germany and Health Care Economy,
since February 2021 Project Manager at the Research Unit "Pharmaceuticals in Germany
Kirchhoff, Jasmina / Schumacher, Simon, 2023, Ökonomische Folgen der Energiepreiskrise am Beispiel der pharmazeutischen Industrie in Deutschland, in: IW-Trends, 50. Jg., Nr. 2, S. 97-114 Zur Studie
Kirchhoff, Jasmina / Malin, Lydia / Schumacher, Simon, 2022, Pharmaindustrie im Wandel. Fachkräftebedarfe in Zeiten transformatorischer Herausforderungen, in: IW-Trends, 49. Jg., Nr. 2, S. 97-116 Zur Studie
Kirchhoff, Jasmina, 2022, Vorleistungsverflechtungen der deutschen Pharmaindustrie im internationalen Vergleich, in: IW-Trends, 49. Jg., Nr. 1, S. 3-19 Zur Studie
Kirchhoff, Jasmina, 2021, Mehr Arzneimittel „made in Germany“ über internationale Vernetzung. Industriepolitische Handlungsempfehlungen für eine zukunftsfähige Pharmaindustrie, IW-Policy Paper, Nr. 22, Köln Zur Studie
Pharmaausfuhren trotzen den globalen Unsicherheiten IW-Kurzbericht 26/2019
Deutschlands Pharmaindustrie 2017/2018 – Turbulentes Jahr 2017, gedämpfte Aussichten für 2018 IW-Report 42/2018
(in cooperation with Anastasia Diel) Gibt es einen Fachkräfteengpass in der deutschen Pharmaindustrie? IW-Trends 3/2018
Die pharmazeutische Industrie in Deutschland – Ein Branchenportrait 4. Auflage des Branchenportraits
(in cooperation with Christian Rusche) Versandhandel – Keine Bedrohung für den Apothekenmarkt IW-Kurzbericht 15/2018
(in cooperation with Anastasia Diel) Geringe Dynamik im Inlandsgeschäft IW-Report 36/2017
Robuste Entwicklung trotz steigender Unsicherheit IW-Kurzbericht 70/2017
Pharmaindustrie in Deutschland – Positive Entwicklung in 2015 IW-Report 15/2016
Musterpräsentation - Daten und Fakten der Pharmaindustrie Pharmastandort Deutschland, 2016
Regionale Beschäftigungsstruktur wissensintensiver Industrien am Beispiel der Pharmabranche IW-Trends 3/2014
Wissensbasis und regionale Agglomeration – Zwei Pharmacluster im Vergleich IW-Trends 4/2012
(in cooperation with Jochen Pimpertz) Gesundheitswesen – Wachstumsmotor mit Fragezeichen Institut der deutschen Wirtschaft Köln (Hrsg.): Wirtschaftswachstum?! – Warum wir wachsen sollten und warum wir wachsen können, IW-Studien, Köln 2012, S. 131–147
Beschäftigungsstrukturen in hochinnovativen Branchen IW-Trends 4/2010
Die forschenden Pharma-Unternehmen im Konjunkturverlauf IW-Trends 1/2010
Expertises
(in cooperation with Anastasia Diel) Daten und Fakten: Die deutsche Pharmaindustrie Musterpräsentation im Auftrag des Verbands der forschenden Pharma-Unternehmen (vfa)
(in cooperation with Anastasia Diel) Daten und Fakten der Pharmaindustrie in Baden-Württemberg Studie für den vfa, 2018
(in cooperation with Anastasia Diel) Daten und Fakten der Pharmaindustrie in Berlin Studie für den vfa, 2018
(in cooperation with Anastasia Diel) Daten und Fakten der Pharmaindustrie in NRW Studie für den vfa, 2018
(in cooperation with Anastasia Diel) Daten und Fakten der Pharmaindustrie in Hessen Studie für den vfa, 2018
(in cooperation with Anastasia Diel) Daten und Fakten der Pharmaindustrie in Rheinland-Pfalz Studie für den vfa, 2018
(in cooperation with Jochen Pimpertz) Bewährtes schützt Vertraulichkeit und schafft Vertrauen Forschungsstelle Pharmastandort Deutschland, Ordnungspolitisches Statement, 2016
Die pharmazeutische Industrie in Deutschland Forschungsstelle Pharmastandort Deutschland, 3. Auflage des Branchenportraits, 2015
External Publications
Internationalization of Innovation Systems – Lessons from Eastern Europe Kovac, Hamburg 2009, 395 Seiten (Euro-Wirtschaft: Studien zur ökonomischen Entwicklung Europas, 35), Zugl.: Univ., Diss., Bielefeld, 2009
The Applicability of the Concept of National Innovation Systems to Transition Economies Innovation: Management, Policy & Practice, Issue 1, Vol. 9, 2007
National Innovation Systems in Transition Countries – The Impact of Institutional Organization and Change Paper for the DRUID Tenth Anniversary Summer Conference, 2005
The Economic Consequences of the Energy Price Crisis as Exemplified by the Pharmaceutical Industry in Germany
Jasmina Kirchhoff / Simon Schumacher
The halting of the Russian gas supply is threatening the attractiveness of Germany as an industrial location. Not only has the energy price crisis led to significantly increased producer prices in the industrial sector.
Pharmaceuticals in Transition: The Need for Skilled Labour in an Era of Digital Transformation
Jasmina Kirchhoff / Lydia Malin / Simon Schumacher
The shortage of skilled workers is increasingly confronting companies in Germany with major challenges. In view of the demographic and transformational tasks, there is a considerable danger that this situation will exacerbate.
Jasmina Kirchhoff / Lydia Malin / Simon Schumacher IW
Where the German Pharmaceutical Industry Sources its Intermediate Inputs: An International Comparison
Jasmina Kirchhoff
The Corona pandemic has led to increasing demands for the reshoring of pharmaceutical production back to Germany. A strategic dependence on non-European active ingredient and drug manufacturers is cited as an argument.
More medicines "made in Germany" via international networking
Jasmina Kirchhoff
The Corona pandemic has put the German pharmaceutical industry more than ever in the focus of political and social discussions. At an unprecedented speed, pharmaceutical companies have developed and brought to market four vaccines approved in Europe – German companies have played a major role in this success.
Production Structures and Supply Chains in the German Pharmaceutical Sector
Michael Grömling / Jasmina Kirchhoff
The corona pandemic has reinforced earlier calls for national sovereignty over critical technologies, with policymakers, the business world and society as a whole focusing their attention particularly on the pharmaceutical industry.
This report is an analysis of the scientific publications on the fight against the corona pandemic and its significance for Germany as a pharmaceutical location.
Jasmina Kirchhoff / Armin Mertens / Marc Scheufen IW
Is There a Shortage of Skilled Workers in the German Pharmaceutical Industry?
Anastasia Diel / Jasmina Kirchhoff
Due to its specific employment structure, the pharmaceutical industry is increasingly being affected by Germany’s widely attested labour shortage. Although in general companies in the sector are actually less affected by bottlenecks than other industries, this is no reason for complacency.
The Regional Employment Structure of Knowledge-Intensive Industries as Exemplified by the Pharmaceutical Industry
Jasmina Kirchhoff
Research-intensive sectors such as pharmaceuticals are a favourite focus of regional policy thanks to their favourable growth prospects. Since, in Germany, the importance of the pharmaceutical industry for regional manufacturing centres and the range and levels of skills in the sector itself differ widely from region to region, it is particularly suitable for an analysis of how factors such as industrial structure and human capital influence the regional significance and skill structures of knowledge-intensive industries. The results of the study suggest that, when locating plants, pharmaceutical companies consider both the structure of local manufacturing and the local population’s level of education. However, other factors seem to be more important for the development of the regional employment structure.
This website uses necessary cookies to ensure the operation of the website. An analysis of user behavior by third parties does not take place. You can find detailed information about the use of cookies in our privacy policy.
Warning: You are using an outdated browser!
Please switch to a modern browser (e.g. Google Chrome, Firefox or Microsoft Edge) in order to enjoy the best user experience.
